Amyotrophic lateral sclerosis

@article{Kiernan2011AmyotrophicLS,
  title={Amyotrophic lateral sclerosis},
  author={Matthew C. Kiernan and Steve Vucic and Benjamin C. Cheah and Martin R. Turner and A. Eisen and Orla Hardiman and James R. Burrell and Margaret C. Zoing},
  journal={The Lancet},
  year={2011},
  volume={377},
  pages={942-955}
}

Figures from this paper

Amyotrophic Lateral Sclerosis

TLDR
This chapter extensively discusses this neurodegenerative disorder based on the currently available knowledge on the condition and suggests treatments available that can help control symptoms, prevent unnecessary complications, and make living with the disease easier.

Amyotrophic Lateral Sclerosis: An Aging-Related Disease

TLDR
It is now recognized that the definition of familial ALS can be enlarged to include family members with frontotemporal dementia considering the tight link between the two nosological entities.

Amyotrophic lateral sclerosis: a long preclinical period?

TLDR
It is suggested, by analogy with other neurodegenerations and from SOD1 ALS mouse studies, that vulnerability might be induced in the perinatal period.

Conjugal Amyotrophic Lateral Sclerosis

TLDR
A case of conjugal ALS is encountered in the outpatient neurology clinic and is reported to be even rarer than sporadic ALS.

Amyotrophic Lateral Sclerosis Disease and Environmental Risk Factors

TLDR
The aim of this chapter was to examine the association between the risk of amyotrophic lateral sclerosis (ALS) and exposure to pesticides and heavy metals.

Functional Biomarkers for Amyotrophic Lateral Sclerosis

TLDR
An overview of recently developed novel non-invasive electrophysiological techniques that may serve as biomarkers to assess UMN and LMN dysfunction in ALS patients is provided.

Amyotrophic lateral sclerosis and frontotemporal dementia

  • M. Kiernan
  • Psychology
    Journal of Neurology, Neurosurgery & Psychiatry
  • 2012
In the first of JNNP 's mini-themed issues, we investigate how clinical research is making in-roads in the search for the common and overlapping threads that bind amyotrophic lateral sclerosis (ALS)

Genotype-phenotype correlations of amyotrophic lateral sclerosis

TLDR
This review will delineate the clinical features of ALS, outline the major ALS-related genes, and summarize the possible genotype-phenotype correlations of ALS.

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis

TLDR
Although promising neuroimaging biomarker candidates for diagnosis, prognosis, and disease progression have emerged, these have been from the study of necessarily select patient cohorts identified in specialized referral centers, and further multicenter research is now needed to establish their validity as therapeutic outcome measures.

Amyotrophic Lateral Sclerosis: Epidemiology and Risk Factors

TLDR
The only certain risk factors for ALS are positive family history, male gender, and advancing age; among environmental factors, cigarette smoking is supported by the most robust evidence, whereas others are less well documented.
...

References

SHOWING 1-10 OF 429 REFERENCES

Managing patients with amyotrophic lateral sclerosis.

  • S. Sathasivam
  • Medicine, Psychology
    European journal of internal medicine
  • 2009

Biomarkers in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS): A phylogenetic disease of the corticomotoneuron?

It is proposed that the primary cell involved in amyotrophic lateral sclerosis (ALS) is the corticomotoneuron. The spinal motoneuron becomes affected as a result of antegrade effects. This hypothesis

Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications.

TLDR
The clinical implication of these findings is that promising therapeutic approaches can be derived from multidrug treatments aimed at the simultaneous interception of damage in both motor neurons and nonmotor neuronal cells.

Amyotrophic lateral sclerosis.

TLDR
Tremendous progress has been made in the field of ALS based on recent neuropathological and genetic discoveries and the role of metabolism and nutrition in the pathogenesis of the disease is debated and may potentially serve as a future therapeutic target.

Cognitive impairment in amyotrophic lateral sclerosis

Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review

TLDR
In the present review, the pertinent clinical, genetic, neuropathological, neuropsychological and neuroimaging data of the literature are comprehensively and critically discussed and the distinct and overlapping features of ALS and FTD are pointed out.

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

TLDR
An overview of the mechanisms for motor neuron death and the role of non-neuronal cells in ALS is presented and new insights are generated into the diverse molecular pathways involved in ALS pathogenesis.

Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?

  • M. TurnerM. Kiernan
  • Psychology, Biology
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
  • 2012
TLDR
If correct, therapies aimed specifically at supporting interneuronal function may provide a novel therapeutic strategy in ALS pathogenesis.

Mutations of optineurin in amyotrophic lateral sclerosis

TLDR
It is shown that there are mutations in the gene encoding optineurin (OPTN), earlier reported to be a causative gene of primary open-angle glaucoma (POAG), in patients with ALS and these findings strongly suggest that OPTN is involved in the pathogenesis of ALS.
...